Adam is a curious and highly motivated biologist and drug discovery scientist. He joined Entact Bio as part of the translational research team and is excited to be working with such a collaborative and interdisciplinary team. He believes that the approach that Entact Bio has taken to enhance protein function is truly paradigm shifting and will have an incalculable impact on the lives of patients and their families.
Prior to joining Entact Bio, Adam worked as a Senior Scientist at Casma Therapeutics where he helped pioneer their autophagy-based targeted degradation platform. Before this, Adam completed his post-doctoral work on the connection between lysosomal biology and Parkinson’s disease, at Harvard Medical School. Adam received his B.Sc. in Biochemistry and Ph.D. in Biomolecular & Biomedical Science from University College Dublin, Ireland.
In his free time Adam enjoys hiking, going for walks around Boston’s numerous parks and green spaces, and travelling with his family.